Expression-based, consistent biomarkers for prognosis and diagnosis in lung cancer.

Macarena Arroyo Varela R Larrosa J Gómez-Maldonado Manuel Cobo Manuel Gonzalo Claros Rocio Bautista

Published in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico (2020)

This prospective study presents evidences for the diagnostic and prognostic capabilities of expression changes in CAPN8-2, TMC5 and MUC1 in LUAD, while they are non-significant in SCLC and lSCC. Their translation to clinical practice is proposed.

Keyphrases

poor prognosis
clinical practice
long non coding rna